ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 142

Prevalence of Subclinical Entheseal Involvement in Patients with Paediatric Inflammatory Bowel Disease: An Ultrasonographic Study

Alberto Batticciotto1, Dario Dilillo2, Marco Antivalle3, Martina Nugnes2, Valentina Varisco1, Matteo Ferrari2, F. Atzeni3, Gian Vincenzo Zuccotti2 and P. Sarzi-Puttini3, 1Rheumatology, L. Sacco University Hospital, Milano, Italy, 2Pediatric Department, L. Sacco University Hospital of Milan, Milan, Italy, 3Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Bowel, Enthesitis, Enthesopathy, pediatrics and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose

Joint involvement is the most frequent extra-intestinal manifestation of paediatric inflammatory bowel disease (IBD). Various recent studies focused on the clinical prevalence of enthesitis in children and adults with IBD1, and others have demonstrated the ability of ultrasound (US) to visualise the acute and chronic signs of entheseal inflammation with greater sensitivity than a clinical examination, although  there is a lack of consensus concerning the US definition of entheseal abnormalities and their prognostic value especially in the paediatric field2. The aim of this study was to evaluate the prevalence of subclinical entheseal involvement in patients with pediatric IBD using a high frequency ultrasound probe. 

Methods

Twenty-seven pediatric IBD patients (13 with Crohn’s disease [CD] and 14 with ulcerative colitis [UC]; 15 females and 12 males; mean age 13.7 years, range 7-21 years) without any clinical signs or symptoms of musculo-skeletal involvement and 24 healthy age- and gender-matched controls (14 females and 13 males; mean age 14.2 years, range 8-20 years) underwent an US examination (ESAOTE MyLAB 70 6-18 MHz linear array transducer). Brachial triceps, femoral quadriceps, Achilles, plantar fascia, and proximal and distal patellar entheses were all scored using the 0-136 Madrid Sonographic Enthesis Index (MASEI). Clinical and clinimetrical variables were assessed in both groups (MASES, BASDAI, BASFI, cHAQ, PCAI/PCDAI).

Results

None of the patients had a MASEI score suggesting early spondyloarthritis involvement but their average score was significantly higher than controls (3.15±2.84 vs 0.96±1.12, p=0.0006). There was also a significantly higher percentage of patients with at least one enthesis with power Doppler (PD) score ≥2 (37% vs 16%; p= 0.037) and at least one enthesis with dishomogeneous echostructure (59% vs 0%; p= 0.000). There were no between-group differences in terms of erosions (0% vs 0%), calcifications (7.4% vs 12.5%; p=0.656) or structural thickness (37% vs33.3%; p=0.507). In paediatric IBD group we cannot find correlation between the total MASEI score and gender (p=0.12), age (p=0.20), disease duration (p=0.18) or IBD activity (p=0.83).

Conclusion

US detectable enthesopathy is frequent in paediatric IBD patients without any clinical signs or symptoms of musculo-skeletal involvement. Further studies involving a larger number of patients are needed to confirm these preliminary data.


Disclosure:

A. Batticciotto,
None;

D. Dilillo,
None;

M. Antivalle,
None;

M. Nugnes,
None;

V. Varisco,
None;

M. Ferrari,
None;

F. Atzeni,
None;

G. V. Zuccotti,
None;

P. Sarzi-Puttini,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-subclinical-entheseal-involvement-in-patients-with-paediatric-inflammatory-bowel-disease-an-ultrasonographic-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology